(Q35013414)

5 August 2017

title

Increasing antimalarial drug resistance in Uganda and revision of the national drug policy (English)

1 reference

5 August 2017

0 references

0 references

Kamya MR

1

1 reference

5 August 2017

Bakyaita NN

2

1 reference

5 August 2017

Talisuna AO

3

1 reference

5 August 2017

Were WM

4

1 reference

5 August 2017

Staedke SG

5

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Tropical Medicine and International Health

5 August 2017

published in

1 reference

5 August 2017

volume

7

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

1031-1041

1 reference

A systematic approach to the development of a rational malaria treatment policy in Zambia

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Chloroquine-resistant Plasmodium falciparum in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Making malaria-treatment policy in the face of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Challenges facing antimalarial therapy in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine among schoolchildren in rural Uganda: a comparison between 1995 and 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Systematic review of amodiaquine treatment in uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Effects of artemisinin derivatives on malaria transmissibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Using evidence to change antimalarial drug policy in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

The changing response of Plasmodium falciparum to antimalarial drugs in east Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

Antimalarial drug combination policy: a caveat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2002.00974.X

10.1046/J.1365-3156.2002.00974.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference